Regulatory/Legislative News

The Union of American Eye Care Providers, which is operated by the American Association of Doctors of Optometry, has initiated an antitrust complaint against vision care plans, according to a press release from the organization.

The U.S. Food and Drug Administration has approved Eylea for treatment of diabetic macular edema, according to a Regeneron Pharmaceuticals press release.

The Board of Trustees of the American Optometric Association announced in a press release that it has named Jon Hymes as its new executive director.

The delivery models for health care are in a rapid stage of growth and development to meet the challenges of health care reform. Hospital systems have been part of the landscape for several decades, but in more recent years, they have expanded to include primary care physicians.

The U.S. Food and Drug Administration has granted orphan drug designation for a recombinant human nerve growth factor-based treatment.

Nidek has announced that the U.S. Food and Drug Administration has issued 510(k) clearance for the AL-Scan Optical Biometer.

PHILADELPHIA – Here at Optometry’s Meeting, a panel presented results of the National Eye Care Workforce Study and predicted an increased need for medical eye care.

PHILADELPHIA – The American Optometric Association has assembled a guideline-development group to formulate evidence-based optometry guidelines to align with new standards from the Institute of Medicine, according to a poster here at Optometry’s Meeting.

PHILADELPHIA – David A. Cockrell, OD, of Stillwater, Okla., was sworn in as the 2014-2015 American Optometric Association president in the AOA’s House of Delegates June 28, here at Optometry’s Meeting.

PHILADELPHIA – While a number of states have passed legislation granting laser and injection privileges and protection against managed care plan dictates, “there’s a huge complacency issue,” the American Optometric Association State Government Relations Committee chair told the House of Delegates.